discontinuing glp-1 Discontinuation and Reinitiation of Receptor Agonists Among US Adults with Overweight or Obesity New research from @doctorsigh shows

In long-term treatment, it improved glycaemic control, reduced IR, and favorably modulated lipid metabolism in patients with T2DM, highlighting a promising strategy for oral GLP-1RA delivery [119] ( Fig

10.3390/biomedicines13081831 76 SalimS.AhmadF.BanuA.MohammadF

Love this protein! Kelly N

[DOI] [PubMed] [Google Scholar] 118.Jastreboff AM, Aronne LJ, Ahmad NN, et al

Has a BMI in the Overweight or Obese Range: This typically indicates individuals who might benefit more from medical intervention than just traditional methods

Older Americans have been waiting for access to the same standard of care that is increasingly available in commercial plans, and for the first time a pathway has opened to provide that access